Roche Launches Test Assessing Drug Metabolism; Psychiatrists Targeted
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics is targeting psychiatrists with a medical education program as part of the launch of its AmpliChip CYP450 genomic test, which assesses how patients metabolize certain drugs